Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06810245 · ClinicalTrials.gov registry record · Phase 1

Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain

A Phase 1 study of Chronic Low Back Pain and Chronic Osteoarthritis Pain, sponsored by Contineum Therapeutics.

Completed
Registry status
Phase 1
Development phase
43
Enrollment target
5
Study locations

NCT06810245 is a Phase 1 study of Chronic Low Back Pain and Chronic Osteoarthritis Pain that has completed, run by Contineum Therapeutics. The registered enrollment target is 43 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (93% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06810245, a Phase 1 study of Chronic Low Back Pain and Chronic Osteoarthritis Pain, has completed, sponsored by Contineum Therapeutics.

COMPLETED
Registry status
Phase 1
Development phase
43 participants
Enrollment target
5
Study locations

Study Summary

The primary goal of this clinical trial is to learn if PIPE-791 is safe and well-tolerated in adults with chronic osteoarthritis pain (COAP) or chronic low back pain (CLBP). The study will also explore whether PIPE-791 lowers pain in people with COAP or CLBP. Subjects will: * Complete a washout period to stop their current pain medications. * Take a daily dose of PIPE-791 or placebo for 4 weeks, then reverse treatment assignment for another 4 weeks. * Record pain levels and track dosing in a daily e-diary. * Visit the clinic for checkups and lab tests throughout the study. * Complete phone assessments during the treatment periods.

Conditions Studied

Chronic Low Back Pain Chronic Osteoarthritis Pain

Interventions

  • DRUG Placebo
  • DRUG PIPE-791

Study Locations (5)

Arizona

  • Arizona Research Center - Phoenix

Georgia

  • Drug Studies America - Marietta

New York

  • Drug Trials America - Hartsdale

Pennsylvania

  • Altoona Center of Clinical Research - Duncansville

Utah

  • JBR Clinical Research - Salt Lake City

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2025-02-04
Est. Completion 2026-01-20
Phase Phase 1

Sponsor

Contineum Therapeutics

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06810245

The ClinicalTrials.gov registry entry for NCT06810245 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (93% lower). The listed sponsor is Contineum Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06810245 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, Georgia, New York.

Frequently Asked Questions

What is clinical trial NCT06810245 about?

NCT06810245 is a clinical study titled "Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain". The primary goal of this clinical trial is to learn if PIPE-791 is safe and well-tolerated in adults with chronic osteoarthritis pain (COAP) or chronic low back pain (CLBP). The study will also explore whether PIPE-791 lowers pain in people with COAP or CLBP. Subjects will: * Complete a washout pe...

What is the current status of trial NCT06810245?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2025-02-04. Estimated completion is 2026-01-20.

What conditions does trial NCT06810245 study?

This clinical trial studies the following conditions: Chronic Low Back Pain, Chronic Osteoarthritis Pain.

What interventions are being tested in trial NCT06810245?

The interventions under investigation include: Placebo (DRUG), PIPE-791 (DRUG).

Who is sponsoring clinical trial NCT06810245?

This trial is sponsored by Contineum Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06810245 being conducted?

This trial has 5 study locations across Arizona, Georgia, New York, Pennsylvania, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Low Back Pain

All registered trials for this condition

Chronic Osteoarthritis Pain

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.